Drug
Leo 32731 Modified Release
Leo 32731 Modified Release: highest development phase Phase 1, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEO 32731 modified release tablet NCT03812198 | Phase 1 | Healthy |
Latest
No recent events.
Follow Leo 32731 Modified Release on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.